Insta
In Maiden Meet, Indian And Chinese Drug Regulators Discuss More Access For Indian Exporters To Pharma Market In China
India and China flags. (Representative image)
In the first ever meeting of Indian and Chinese drug regulators, Indian representatives pressed their counterparts for a clear roadmap to open up the Chinese pharmaceuticals market for Indian exports, reports The Economic Times.
The crucial meeting took place on Friday (21 June) at Shanghai. The meeting gains significance as Indian officials have for long been pressing over China to allow Indian companies wider access to the Chinese pharmaceuticals market which is presently under pressure because of high prices of cancer and generic drugs.
The meeting went on for as much as nine hours and included senior officials from the Ministry of Commerce and also diplomats to aid the discussion. The Indian Ambassador to China, Vikram Misri, also emphasised the need to hold such meetings in a regular fashion.
The meeting deliberated upon different subjects in six sessions, such as regulatory overview of the National Medical Products Administration (NMPA), registration of imported drugs in China, Indian regulatory system, drug procurement system in China, NMPA overseas inspections and compliance guide, API (Active Pharmaceutical Ingredient) registration process in China.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
